CARDIOSKIN

Active

Private limited company (pre-2019)founded 1999active for 27 yearsVictor Gilsoullaan 47, 1200 Sint-Lambrechts-Woluwe, BelgiumKBO/BCE: BE 0466.119.939

Summary

CARDIOSKIN has been active since 1999 and the Belgian Official Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €208,367 and a net result of €68,325. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 53% of 19,744 sector peers (NACE 86, financial year 2024). The computed 12-month bankruptcy probability is 0.2% (very low).

Risk analysisFollow Report Compare

CARDIOSKINActiveChecked score 56/100

Risk analysis Report Compare

Activity

Specialist medical practice

NACE 86220

1 site

Size

€298,186total assets 2024

Staff: 0.2 FTE
Equity: €208,367
Profit: €68,325

Turnover not published (micro format)

Financial health

56 Fair Checked score 2024

Bankruptcy probabilitywithin 12 months: 0.2%

Structure

2025 accounts not filed, 89 days past the deadline1 deed in the Belgian Official Gazette

Why 56raises riskCapped at 59: a confirmed filing findingFigures for financial year 2024 (filed 19-08-2025)1 financial year not filed after the legal deadline; last filed accounts filed 18 days late; 2 of the last 3 latelowers riskSector: Human health activities (NACE 86)Founded in 1999Show the evidence

Checked score

Score 2024

56 / 100

Fair

Probability in this band: 1.5% to 4.2%

Financially better than 59% of its sector peers (NACE 86, micro)

A confirmed filing finding caps the score at 59. Every signal that counts is listed under Signals.

Financial strength · tick = 2023

Strong

Solvency 95+21

equity 69.9% of total assets

Liquidity 62-4

short-term debt 11.8% · cash 10.4%

Profitability 97-3

return on assets 22.9%

Bankruptcy probability, 12 months

0.2% Very low

0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,126 companies, NACE 86, micro)

Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024lowest value 02-2025: 0.1%● unchanged vs 01-2025lowest value 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.2%▲ +0.1 percentage points vs 07-2026 09-2026: 0.2%● unchanged vs 08-2026 10-2026: 0.2%● unchanged vs 09-2026highest value

Credit of up to €11,000 on 30-day terms, only on tighter conditions: an expected filing is missing beyond Checked's processing allowance

Liquidity ample (current ratio 4.35, compared with 1.71 in 2023, above the usual 1.5; short-term debt: 11.8% and cash: 10.4% of total assets), and 30.1% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 58% on solvency, 40% on liquidity, 57% on profitability and 80% on growth.

The bankruptcy probability was computed on 27-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Seven signals.

lowers riskraises risk

Sector: Human health activities (NACE 86)

KBO

Figures for financial year 2024 (filed 19-08-2025)

NBB · annual accounts

1 financial year not filed after the legal deadline; last filed accounts filed 18 days late; 2 of the last 3 late

NBB · filings

Founded in 1999

Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.

KBO

Growing equity

Reported equity is higher than in 2022 and did not fall compared with 2023. These amounts do not establish the cause of the change.

NBB · annual accounts 2024

Equity per financial year

18192021222324

2018 to 2024 · latest year €208,367

Annual accounts not filed

The financial year that closed on 31-12-2025 was due at the National Bank by 31-07-2026. Nothing is on record, 89 days later.

NBB · 10 filings

Position against the passed deadline

31-12-2025 year end31-07-2026 deadline28-10-2026 today

2024 accounts filed 18 days late

The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 18-08-2025, 18 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.

NBB · 10 filings

Deviation from the deadline

2025

not filed

2024

18 days late

2023

68 days late

2022

32 days late

2021

79 days late

2020

51 days late

2019

108 days late

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 6 accounts on average 59 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (1)

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

18-08-2025 Annual accounts filedfinancial year 2024 · micro…
31-12-2024 Liquidity more than doubledcurrent ratio 4.35
31-12-2024 Equity above €200,000equity €208,367 ▲48.8%

Key points

Caution: 2025 accounts not fileddeadline was 31-07-2026 89 days past the deadline View
Positive: Equity rose in 2024from €140,041 to €208,367 ▲ 48.8% View
Active since 1999founded 28-05-1999 27 years View

By topic

Financials

Financial year: 2024
Total assets: €298,186
Profit: €68,325
Solvency: 69.9%

Total assets▲ 4.4%

Net result

20182024

Go to Financials

Timeline

Events: 32
Since: 2001

07-10-2024Annual accounts filed
31-12-2023Highest result from 2018 to 2024
01-09-2023Annual accounts filed

Go to Timeline

Company details

Sites: 1

Legal form: Private limited company (pre-2019)
Activity: Specialist medical practiceNACE 86220
Founded: 28-05-1999
Year ends: 31-12
Peppol: Reachable for e-invoices

Go to Company details

Key facts about CARDIOSKIN

What is the company number of CARDIOSKIN?: 0466.119.939. In Belgium the VAT number is the company number with BE in front: BE 0466.119.939.
Where is CARDIOSKIN based?: The registered office is at Victor Gilsoullaan 47, 1200 Sint-Lambrechts-Woluwe.Company details
What does CARDIOSKIN do?: According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of CARDIOSKIN?: Private limited company (pre-2019) (BVBA).
When was CARDIOSKIN founded?: On 28-05-1999.
Is CARDIOSKIN still active?: Yes, CARDIOSKIN is an active enterprise in the KBO register.
How many employees does CARDIOSKIN have?: On average 0.2 full-time equivalents in financial year 2024, according to the filed annual accounts.Financials
What is the turnover of CARDIOSKIN?: Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is CARDIOSKIN profitable?: In financial year 2024, CARDIOSKIN made a profit of €68,325.
Where can I find the annual accounts of CARDIOSKIN?: CARDIOSKIN filed 25 annual accounts with the National Bank of Belgium, the latest for financial year 2024.